Tel: 732-484-9848
Fax: 888-484-5008
Email: [email protected]
   
Building blocks
Intermediates
Bioactive molecules
Product Pathways
All Targets
Anti-infection
Antibody-drug conjugate....
Apoptosis
Autophagy
Biochemical Reagent
Cell Cycle/DNA Damage
Cytoskeleton
Epigenetics
GPCR/G protein
Immunology/Inflammation
JAK/STAT Signaling
MAPK/ERK Pathway
Membrane Transporter/Io....
Metabolic Enzyme/Protease
Neuronal Signaling
NF-κB
Others
PI3K/Akt/mTOR
Protein Tyrosine Kinase....
Stem Cells/Wnt
TGF-beta/Smad
Vitamin D Related
Research Area
Cancer
Cardiovascular Disease
Endocrinology
Infection
Metabolic Disease
Neurological Disease
Others
Inflammation/Immunology
Product Type
All Products
New Products
Featured Products
Home   »   Product Pathways  »  TRP Channel  »  SB-705498

Products are for research use only. Not for human use. We do not sell to patients.


CS-0757 SB-705498


(SB 705498;SB705498)
Structure Price and Availability of    SB-705498
United States
Size Price Stock
5mg $80 In-stock Inquiry
10mg $150 In-stock
50mg $650 In-stock
100mg $1050 In-stock
200 mg Get quote
500 mg Get quote
 Distributor In Japan:  フナコシ株式会社 www.funakoshi.co.jp    電話番号:81-3-5684-1620   
 FAX番号:81-3-5684-1775
Inquiry for price and availability only. Please place your order via our email or fax.
Contact us for competitive discounts on bulk quantities .
  • Data Sheet
  • Introduction
  • References
  • Related Products

SB-705498  M.Wt:  429.23
SB-705498  Formula: C17H16BrF3N4O
SB-705498  Solubility: DMSO ≥80mg/mL; Water <1mg/mL; Ethanol ≥20mg/mL
SB-705498  Purity: >98%
SB-705498  Storage:  Please store the product under the recommended conditions in the Certificate of Analysis.
CAS: 501951-42-4

View current batch:

SB-705498 is a potent, selective and orally bioavailable transient receptor potential vanilloid 1 (TRPV1) receptor antagonist with a pIC50 of 7.1. IC50 value: 7.1 (pIC50) Target: TRPV1 SB-705498 potently inhibits capsaicin-induced activation of human TRPV1 expressed in 1321N1 cells or HEK293 cells with apparent pKi of 7.5 or 7.6, respectively. Coapplication of 100 nM SB-705498 rapidly, completely and reversibly inhibits hTRPV1 expressed in HEK293 cells. Compared with placebo, SB-705498 reduced the area of capsaicin-evoked flare (P=0.0047). The heat pain threshold on non-sensitised skin was elevated following SB-705498 (estimated difference from placebo [95% confidence intervals]: 1.3 degrees C [0.07,2.53], P=0.019). Following capsaicin sensitisation, the heat pain threshold and tolerance were similar between SB-705498 and placebo. However, SB-705498 increased heat pain tolerance at the site of UVB-evoked inflammation (estimated difference from placebo: 0.93 degrees C [0.25,1.6], P=0.0054). The magnitude of the pharmacodynamic effects of SB-705498 appeared to be related to plasma concentration. These results indicate that SB-705498, at a clinically safe and well-tolerated dose, has target-specific pharmacodynamic activity in humans. These data provide the first clinical evidence that a TRPV1 antagonist may alleviate pain and hyperalgesia associated with inflammation and tissue injury.

TRP Channel  |  
Keywords: buy SB-705498 | SB-705498 Supplier | purchase SB-705498 | SB-705498 cost | SB-705498 manufacturer | order SB-705498 | SB-705498 distributor | SB-705498 structure,chemscene
buy 501951-42-4 | 501951-42-4 Supplier | purchase 501951-42-4 | 501951-42-4 cost | 501951-42-4 manufacturer | order 501951-42-4 | 501951-42-4 distributor | 501951-42-4 structure,chemscene


CHEMSCENE, LLC
Tel: 732-484-9848
Fax: 888-484-5008
Email:  [email protected]
Address: 11 Deer Park Drive, Suite 102D Monmouth Junction, NJ 08852.
Products are for research use only. Not for human use. We do not sell to patients. Sitemap | Inhibitor © Copyright 2012. All Rights Reserved.